Efficacy And Safety Of Nintedanib In Patients With Idiopathic Pulmonary Fibrosis: Results Of Two 52-Week, Phase Iii, Randomized, Placebo-Controlled Trials (inpulsis (TM)) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Richeldi, L
  • Du Bois, R
  • Raghu, G
  • Azuma, A
  • Brown, KK
  • Costabel, U
  • Cottin, V
  • Flaherty, K
  • Inoue, Y
  • Kim, D
  • Kolb, Martin Rainer
  • Noble, PW
  • Selman, M
  • Taniguchi, H
  • Brun, M
  • Girard, M
  • Schlenker-Herceg, R
  • Disse, B
  • Collard, HR

publication date

  • January 1, 2014